Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$518M |
| 2 |
Citigroup
C
|
+$271M |
| 3 |
Bank of America
BAC
|
+$254M |
| 4 |
RTX Corp
RTX
|
+$233M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$507M |
| 2 |
British American Tobacco
BTI
|
+$298M |
| 3 |
Vodafone
VOD
|
+$272M |
| 4 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$267M |
| 5 |
BHP
BHP
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 14.63% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 7.86% |
| 5 | Industrials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Steris
STE
$22.5B
| $72.9M | 0.18% |
1,695,861
-8,272
| -0.5% | -$359K |
|
77
Ingredion
INGR
$6.33B
| $72.7M | 0.18% |
1,098,533
-92,031
| -8% | -$6.01M |
|
78
Raymond James Financial
RJF
$33.6B
| $72.1M | 0.18% |
2,595,866
+41,565
| +2% | +$1.2M |
|
79
Perrigo
PRGO
$1.43B
| $72M | 0.18% |
583,782
+3,220
| +0.6% | +$402K |
|
|
SYT
80
DELISTED
Syngenta Ag
SYT
| $71.2M | 0.18% |
875,740
+1,811
| +0.2% | +$145K |
|
|
FCS
81
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $71.2M | 0.18% |
5,124,997
+11,805
| +0.2% | +$155K |
|
|
AXE
82
DELISTED
Anixter International Inc
AXE
| $71M | 0.18% |
809,878
+625
| +0.1% | +$52.4K |
|
|
LSI
83
DELISTED
Life Storage, Inc.
LSI
| $71M | 0.17% |
1,406,486
-51,360
| -4% | -$2.41M |
|
|
JAH
84
DELISTED
JARDEN CORPORATION
JAH
| $70.6M | 0.17% |
2,189,039
-24,697
| -1% | -$762K |
|
|
LUX
85
DELISTED
Luxottica Group
LUX
| $69.7M | 0.17% |
1,325,709
+2,862
| +0.2% | +$152K |
|
|
ARMH
86
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $67M | 0.17% |
1,392,065
+1,179,822
| +556% | +$49.8M |
|
|
HRC
87
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $66.1M | 0.16% |
1,845,754
-3,105
| -0.2% | -$110K |
|
|
TTM
88
DELISTED
Tata Motors Limited
TTM
| $65.5M | 0.16% |
2,460,791
+102,895
| +4% | +$2.53M |
|
89
Smith & Nephew
SNN
$13.6B
| $65.4M | 0.16% |
2,620,953
-3,080
| -0.1% | -$74.3K |
|
|
CYT
90
DELISTED
CYTEC INDS INC
CYT
| $65M | 0.16% |
1,599,024
-4,410
| -0.3% | -$171K |
|
|
WMGI
91
DELISTED
Wright Medical Group Inc
WMGI
| $64.9M | 0.16% |
2,488,884
-5,570
| -0.2% | -$145K |
|
92
Oceaneering
OII
$4.74B
| $64.6M | 0.16% |
795,281
-51,802
| -6% | -$4.16M |
|
|
93
British American Tobacco
BTI
$133B
| $64.2M | 0.16% |
1,220,562
-5,630,606
| -82% | -$298M |
|
94
Helmerich & Payne
HP
$3.37B
| $63.4M | 0.16% |
920,175
-5,650
| -0.6% | -$373K |
|
|
OUTR
95
DELISTED
OUTERWALL INC
OUTR
| $63.1M | 0.16% |
1,261,943
+13,129
| +1% | +$773K |
|
|
THS
96
DELISTED
Treehouse Foods
THS
| $62.8M | 0.15% |
939,622
+23,095
| +3% | +$1.59M |
|
97
Webster Financial
WBS
$12.5B
| $61.9M | 0.15% |
2,424,824
+657,690
| +37% | +$17.5M |
|
98
BP
BP
$114B
| $61.8M | 0.15% |
1,797,787
-733
| -0% | -$25.1K |
|
99
Gilead Sciences
GILD
$163B
| $61.4M | 0.15% |
977,358
-60,010
| -6% | -$3.59M |
|
100
Henry Schein
HSIC
$9.7B
| $60.8M | 0.15% |
1,494,461
-9,781
| -0.7% | -$396K |
|
Similar funds
Ken Fisher's Q3 2013 Portfolio in Review
As of Q3 2013, Ken Fisher held 585 positions worth $40.6B, up 5.4% from $38.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q3 2013 filing shows 60 new, 219 increased, 193 reduced and 51 closed positions. Its largest new stake was Cadence Bank: 2,667,685 shares worth $53.2M. The largest sale was Philip Morris, an estimated $507M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q3 2013 buy was Cadence Bank: 2,667,685 shares worth $53.2M.
- Ken Fisher added most to Barclays ETN+ FI Enhanced Europe 50 ETN in Q3 2013, an estimated $518M increase.
- Ken Fisher's biggest Q3 2013 reduction was Philip Morris, cutting an estimated $507M.
- Ken Fisher fully exited SAKS INCORPORATED in Q3 2013, selling an estimated $75M.
- Ken Fisher's ten largest holdings make up 22% of its $40.6B portfolio in Q3 2013.
- Ken Fisher opened 60 new positions and closed 51 in Q3 2013.
- Ken Fisher's portfolio value rose 5.4% quarter-over-quarter to $40.6B.
Based on Fisher Asset Management's 13F filing for Q3 2013, filed 18 Oct 2013.